News
ABT
100.30
-2.36%
-2.42
Earnings week ahead: JNJ, NFLX, TSM, GS, C, JPM, BAC, PEP, and more
Seeking Alpha · 8h ago
The Week That Was, The Week Ahead: Macro and Markets, April 12
TipRanks · 11h ago
Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus
Seeking Alpha · 1d ago
Abbott ordered to pay $70M in damages in Chicago baby formula case
Seeking Alpha · 1d ago
Big Yachts, Big Bucks
Barron‘s · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of April 12
Seeking Alpha · 1d ago
Abbott owes $17M in damages in baby formula trial, Bloomberg reports
TipRanks · 2d ago
Catalyst Watch: Earnings heat up, Fedspeak flurry, and eyes on space
Seeking Alpha · 2d ago
William Blair health diagnostics analyst holds analyst/industry conference call
TipRanks · 2d ago
Health Care Select Sector SPDR Fund Experiences Big Outflow
NASDAQ · 2d ago
Dividend Roundup: AGNC Investments, Abbott Labs, AbbVie, and more
Seeking Alpha · 2d ago
Abbott Laboratories: Solid Q1 Setup and Resilient MedTech/Diagnostics Support Path to 2026 Targets Amid Manageable Geopolitical Headwinds
TipRanks · 2d ago
How Abbott Baby Formula Verdict and Rising Litigation Risk May Reshape Abbott Laboratories' (ABT) Investment Profile
Simply Wall St · 2d ago
Chicago jury orders Abbott to pay $53M in preterm infant formula trial
Seeking Alpha · 2d ago
What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report
Barchart · 2d ago
Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know
Barchart · 2d ago
Abbott Labs Is Maintained at Buy by Goldman Sachs
Dow Jones · 3d ago
Abbott Labs Price Target Cut to $121.00/Share From $140.00 by Goldman Sachs
Dow Jones · 3d ago
Goldman Sachs Maintains Buy on Abbott Laboratories, Lowers Price Target to $121
Benzinga · 3d ago
March Inflation Set For Biggest Jump Since June 2022 — When CPI Spikes, These Stocks Fall
Benzinga · 3d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.